Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Orteronel in Advanced Granulosa Cell Ovarian Tumors
NCT02101684Phase 2Terminated
- Sponsor
- Grupo Español de Tumores Huérfanos e Infrecuentes
- Start
- Jun 2014
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of orteronel in granulosa cell tumor of the ovary (GCT), sponsored by Grupo Español de Tumores Huérfanos e Infrecuentes. Started Jun 2014; status: terminated.
02
Drugs
orteronel
03
Conditions
granulosa cell tumor of the ovary (GCT)
Beyond the preview
Go deeper on NCT02101684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02101684.